Mark Jacobson - Nov 12, 2021 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Mark Jacobson
Stock symbol
AXSM
Transactions as of
Nov 12, 2021
Transactions value $
$0
Form type
4
Date filed
11/15/2021, 06:54 PM
Next filing
Mar 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Employee Stock Option (Right to Buy) Award $0 +41.6K $0.00 41.6K Nov 12, 2021 Common Stock 41.6K $39.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will start to vest one year from November 12, 2021 and then will vest in substantially equal quarterly installments over three years such that the option will be fully vested on November 12, 2025.